Evidence map›Paper›PMID 30410817›Full record

ReviewTremor and other hyperkinetic movements (New York, N.Y.)2018

Dentatorubral-pallidoluysian Atrophy: An Update.

Liam S Carroll, Thomas H Massey, Mark Wardle, Kathryn J Peall

Open access · greenAbstract readReview
In one paragraph

Review in Tremor and other hyperkinetic movements (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Treatment of primary adult-onset neurodegenerative cerebellar ataxias.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  4. Article
  5. Article
  6. Update on Genetic Chorea.European journal of neurology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Liam S CarrollDepartment of Neurology, Wessex Neurological Centre, Southampton General Hospital, Southampton, UK.
Thomas H MasseyMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Mark WardleUniversity Hospital of Wales, Cardiff and Vale University Health Board, Health Park, Cardiff, UK.
Kathryn J PeallNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK.
Cardiff University · GBCardiff and Vale University Health Board · GBSouthampton General Hospital · GB

Funding

Medical Research Council MR/P001629/1Medical Research Council MR/P008593/1
6 · The paper itself

Abstract

Background: Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare, autosomal dominantly inherited disorder characterized by myoclonus, epilepsy, ataxia, and dementia. Diagnosis is challenging due to the heterogeneous presentation and symptomatic overlap with other spinocerebellar ataxias. Symptoms vary according to age of onset, with a mean age at onset of 31 years. A CAG repeat expansion in the Methods: We performed an online literature search using PubMed for all articles published in an English Language format on the topics of DRPLA or Results: Forty-seven articles were identified, 10 were unobtainable and 10 provided no relevant information. The remaining 27 articles were then used for the review template: seven case reports, seven case series, six model system articles (one review article), four population clinical and genetic studies (one review article), two general review articles, and one human gene expression study. Other cited articles or research from related fields gave a further 42 articles, producing a total of 69 articles cited: 15 case series (including eight family studies), 14 model systems (one review article), 14 population clinical and genetic studies (two review articles), 10 case reports, eight clinical trials/guidelines, four genetic methodology articles, three general review articles, and one human gene expression study. Discussion: DRPLA remains an intractable, progressive, neurodegenerative disorder without effective treatment. Early recognition of the disorder may improve patient understanding, and access to services and treatments. Large-scale studies are lacking, but are required to characterize the full allelic architecture of the disorder in all populations and the heterogeneous phenotypic spectrum, including neuroimaging findings, possible biomarkers, and responses to treatment.

Indexed as

Disease ManagementMyoclonic Epilepsies, ProgressiveAdultAnimalsBrainChildDisease Models, AnimalFemaleHumansMaleNerve Tissue ProteinsPeptidesPubMedatrophin-1Nerve Tissue ProteinsPeptidespolyglutamineataxiaATN1dementiaDRPLAepilepsymyoclonuspolyglutaminetrinucleotide

Identifiers

PMID30410817
PMCPMC6222020
OpenAlexW2895041389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.